Cuprina Holdings (Cayman) LTD (CUPR)
Company
Cuprina Holdings (Cayman) LTD (CUPR)
Apr 10, 2025
Biotechnology
Initial Public Offering / IPOWe are a Singapore-based biomedical and biotechnology company that is dedicated to the development and commercialization of innovative products for the management of chronic wounds, as well as operating in the health and beauty sectors. Our expertise in biomedical research allows us to identify and utilize materials derived from natural sources to develop wound care products in the form of medical devices which meet international standards. For more information, please visit https://www.cuprina.com.
Chart/Sentiment
Financials
Cuprina Holdings (Cayman) LTD (CUPR)
| Period end | Revenue |
|---|---|
2025-12-3120-F | 38,789 USD |
2024-12-3120-F | 35,522 USD |
Source: SEC Company Facts · USD. Some values may be calculated; please verify them against the official SEC filings.






